<DOC>
	<DOCNO>NCT00321880</DOCNO>
	<brief_summary>RATIONALE : Supportive care , heal touch , may improve quality life patient receive chemotherapy acute leukemia . PURPOSE : This clinical trial study well heal touch work treat patient receive chemotherapy acute myeloid leukemia acute lymphocytic leukemia .</brief_summary>
	<brief_title>Healing Touch Treating Patients Receiving Chemotherapy Acute Myeloid Leukemia Acute Lymphocytic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Determine feasibility conduct randomize controlled trial , term recruit retain participant , study heal touch ( HT ) supportive care patient receive chemotherapy acute myeloid leukemia acute lymphoblastic leukemia . - Examine potential barrier participation ascertain reason study drop-outs patient . - Demonstrate whether patient comply treatment session remain study . - Obtain preliminary data effectiveness HT psychological distress treatment-related symptom focus fatigue sleep disturbance patient . - Determine HT protocol need refine , modify , eliminate , base pilot participant feedback , randomize clinical trial . OUTLINE : This pilot study . Within 1 week admission hospital , patient interview research assistant previous use complementary alternative medicine therapy , knowledge heal touch ( HT ) , previous experience HT , willingness participate study HT acute leukemia patient , willingness randomize HT study . The first 12 patient interested undergoing HT undergo 30-minute session HT therapy 3 time week week 2 , 3 , 4 induction reinduction chemotherapy . Patients also ask rate current distress , pain , fatigue , nausea second HT session week 2 , 3 , 4 . Patients also complete self-report questionnaire baseline , week 5 induction reinduction chemotherapy prior discharge hospital , first week consolidation chemotherapy ( approximately week 9-13 ) . PROJECTED ACCRUAL : A total 40 patient accrue study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis one follow acute leukemia : Acute lymphocytic leukemia Acute myeloid leukemia Hospitalized induction ( newly diagnose patient ) reinduction ( relapsed patient ) chemotherapy Must oncology inpatient Wake Forest University Baptist Medical Center PATIENT CHARACTERISTICS : Must know adequate English understand consent form , complete questionnaire , converse study staff PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>fatigue</keyword>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>adult acute myeloid leukemia 11q23 ( MLL ) abnormality</keyword>
	<keyword>adult acute myeloid leukemia inv ( 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 15 ; 17 ) ( q22 ; q12 )</keyword>
	<keyword>adult acute myeloid leukemia ( 16 ; 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 8 ; 21 ) ( q22 ; q22 )</keyword>
	<keyword>recurrent adult acute lymphoblastic leukemia</keyword>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
	<keyword>untreated adult acute lymphoblastic leukemia</keyword>
	<keyword>untreated adult acute myeloid leukemia</keyword>
</DOC>